Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07760831
A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative ColitisJiangsu HengRui Medicine Co., Ltd.Not Yet RecruitingPhase 1
NCT07760831Not Yet Recruiting
Phase 1
A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerativ...Jiangsu HengRui Medicine...
NCT07759973
Neurocomputational Dynamics of CooperationEmory UniversityNot Yet RecruitingNot Applicable
NCT07759973Not Yet Recruiting
Not Applicable
Neurocomputational Dynamics of CooperationEmory University
NCT07761026
The AXIS Registry is a 10-year Longitudinal Research Initiative That Captures the Real-world Experiences of People Living With Autoimmune Neurology Conditions. Launching in Myasthenia Gravis (MG), we Plan to Evaluate Expansion to Other Conditions Across Autoimmune Neurology.Alira HealthRecruiting
NCT07761026Recruiting
—
The AXIS Registry is a 10-year Longitudinal Research Initiative That Captures th...Alira Health
NCT07759778
Oliceridine-Propofol Dose for Gastroscope Insertion in Obese PatientsLu YiNot Yet RecruitingPhase 4
NCT07759778Not Yet Recruiting
Phase 4
Oliceridine-Propofol Dose for Gastroscope Insertion in Obese PatientsLu Yi
NCT07761065
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion in Skeletal Open Bite CasesAin Shams UniversityCompletedNot Applicable
NCT07761065Completed
Not Applicable
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion...Ain Shams University
NCT07761429
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)Shandong New Time Pharmaceutical Co., LTDRecruitingPhase 2
NCT07761429Recruiting
Phase 2
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Tr...Shandong New Time Pharmac...
NCT07760324
CD4 Cell Count at Antiretroviral Therapy Initiation or Re- InitiationCentre for Infectious Disease Research in ZambiaSuspended
NCT07760324Suspended
—
CD4 Cell Count at Antiretroviral Therapy Initiation or Re- InitiationCentre for Infectious Dis...
NCT07759427
Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular TachycardiaUniversity Hospitals Coventry and Warwickshire NHS TrustRecruitingNot Applicable
NCT07759427Recruiting
Not Applicable
Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular Tac...University Hospitals Cove...
NCT07760649
A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in the Treatment of Participants With Ischemic StrokeNeuravi LimitedNot Yet Recruiting
NCT07760649Not Yet Recruiting
—
A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in t...Neuravi Limited
NCT07761143
Impact of Device Free Summer Camp on Adolescent Mental Health and WellbeingRady Children's Hospital, San DiegoCompletedNot Applicable
NCT07761143Completed
Not Applicable
Impact of Device Free Summer Camp on Adolescent Mental Health and WellbeingRady Children's Hospital,...
NCT07760818
A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)argenxNot Yet RecruitingPhase 2
NCT07760818Not Yet Recruiting
Phase 2
A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's D...argenx
NCT07759297
Intraoperative Dexmedetomidine Use and Postoperative Delirium After Cardiac SurgeryShusheng LiCompleted
NCT07759297Completed
—
Intraoperative Dexmedetomidine Use and Postoperative Delirium After Cardiac Surg...Shusheng Li
NCT07761650
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital LahoreCompletedNot Applicable
NCT07761650Completed
Not Applicable
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital Lahore
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07759622
The Cesarean Study: Optimizing Cesarean Sections and Improving Patient-Healthcare Provider Trust Using Evidence Informed RecommendationsLund UniversityRecruitingNot Applicable
NCT07759622Recruiting
Not Applicable
The Cesarean Study: Optimizing Cesarean Sections and Improving Patient-Healthcar...Lund University
NCT07759362
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)Endo USA Inc., a Keenova Therapeutics CompanyNot Yet RecruitingPhase 3
NCT07759362Not Yet Recruiting
Phase 3
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT...Endo USA Inc., a Keenova...
NCT07761793
Diaphragmatic Myofascial Release Added to Neck Exercises for Chronic Neck PainAbdelrahman AlghoulNot Yet RecruitingNot Applicable
NCT07761793Not Yet Recruiting
Not Applicable
Diaphragmatic Myofascial Release Added to Neck Exercises for Chronic Neck PainAbdelrahman Alghoul
NCT07759726
Cellphone Access for Lowered Maternal Anxiety and Stress in Cesarean SectionsBeirut Arab UniversityCompletedNot Applicable
NCT07759726Completed
Not Applicable
Cellphone Access for Lowered Maternal Anxiety and Stress in Cesarean SectionsBeirut Arab University
NCT07759518
Letrozole High Dose (10 mg) Compared to Letrozole Low Dose( 5 mg) for Ovarian Stimulation in Infertile Women With Polycystic Ovary SyndromeMst.Sumyara KhatunCompletedNot Applicable
NCT07759518Completed
Not Applicable
Letrozole High Dose (10 mg) Compared to Letrozole Low Dose( 5 mg) for Ovarian St...Mst.Sumyara Khatun
NCT07761117
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFAstraZenecaNot Yet RecruitingPhase 3
NCT07761117Not Yet Recruiting
Phase 3
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Ad...AstraZeneca
Result Breakdown
Not yet recruiting9 (45%)
Completed6 (30%)
Recruiting4 (20%)
Suspended1 (5%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 22 (10%)
Phase 32 (10%)
Phase 11 (5%)
Phase 41 (5%)